Company Profile

Monon Bioventures LLC (AKA: MBV)
Profile last edited on: 1/24/2018      CAGE: 7E7M0      UEI: QFPDHTYDGBL1

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2015
First Award
2019
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

111227 Knightsbridge Lane
Fishers, IN 46037
   (765) 376-1471
   N/A
   www.mononbioventures.com
Location: Single
Congr. District: 05
County: Hamilton

Public Profile

While management includes a number of proven players with strong scientific backgrounds, Monon Bioventures as a firm describes itself as an "accelerator." partnering with research institutions in Indiana and across the country to help investigators take their idea from the bench to the clinic and into the marketplace. The frim's business model allows scientists to be scientists and to leave the running of the business aspect--everything from getting funding, putting the right talent team around the asset--to Monon. Monon management seek innovative ideas that are game-changers. BY coming in so early, the firm indicates they can take a more risk than a typical venture capitalist and can move the asset into something that is investable.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 1 NIH $399,314
Project Title: Off-the-shelf engineered NK cells to treat glioblastoma
2021 2 NIH $1,298,023
Project Title: Soluble, Solution-Stable Phospho-Glucagon for Hypoglycemic Rescue

Key People / Management

  Gail E Besner

  Michael Fanger

  Neil Fanger

  Mark Louis Heiman

  Jake Reder

  Jim Schulz -- Founder & Chief Financial Officer

  Joe Trebley